Seeking Alpha

Alexion Pharmaceuticals (ALXN +2.8%) makes a new all-time high after receiving an upgrade to Buy...

Alexion Pharmaceuticals (ALXN +2.8%) makes a new all-time high after receiving an upgrade to Buy from UBS. The firm touts the "defensive growth" offered by Alexion's business model, the potential of its Soliris drug in treating multiple diseases, and improving visibility surrounding the rest of Alexion's pipeline.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)